GENB vs PGEN: stock comparison and AI forecast
Generate Biomedicines, Inc. (GENB) and Precigen, Inc. (PGEN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
GENB Generate Biomedicines, Inc.
- Price
- $12.57 -7.5% · 6M
- Market Cap
- $1.61B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
PGEN Precigen, Inc.
- Market Cap
- $1.60B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- GENB and PGEN have similar market capitalizations ($1.61B and $1.60B).
- PGEN carries 1.53 times debt per unit of equity, against 0.23 times for GENB.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | GENB | PGEN |
|---|---|---|
| Market Cap | $1.61B | $1.60B |
| P/B Ratio | 3.54x | 19.10x |
| EPS | – | $-0.23 |
| Book Value/Share | $3.55 | $0.23 |
| Revenue/Share | – | $0.23 |
| FCF/Share | – | $-0.21 |
Profitability & Margins
| Metric | GENB | PGEN |
|---|---|---|
| ROIC | – | -30.4% |
| Operating Margin | – | -65.9% |
| EBT Margin | – | -241.6% |
| Tax Rate | – | -0.1% |
Financial Health
| Metric | GENB | PGEN |
|---|---|---|
| Current Ratio | 8.30x | 5.58x |
| Quick Ratio | – | 4.83x |
| D/E Ratio | 0.23x | 1.53x |
| Financial Leverage | 1.23x | 2.53x |
| Interest Coverage | – | 14.8x |
| Working Capital | $414M | $141M |
Cash Flow
| Metric | GENB | PGEN |
|---|---|---|
| Operating Cash Flow | – | -$73M |
| Free Cash Flow | – | -$74M |
| Capital Spending | – | -$1M |
| FCF/Sales | – | -88.7% |
| CapEx/Sales | – | 1.3% |
Operational Efficiency
| Metric | GENB | PGEN |
|---|---|---|
| Asset Turnover | – | 0.40x |
| Receivables Turnover | – | 0.9x |
| Fixed Assets Turnover | – | 6.3x |
| Days Sales Outstanding | – | 420 days |
Income Statement
| Metric | GENB | PGEN |
|---|---|---|
| Total Revenue | – | $84M |
| Operating Income | – | -$55M |
| R&D Expense | – | $61M |
| SG&A Expense | – | $136M |
Dividend & Shareholder Information
| Metric | GENB | PGEN |
|---|---|---|
| Shares Outstanding | 128M | 358M |
GENB vs PGEN: stock comparison and AI forecast
Which is bigger, GENB or PGEN?
GENB and PGEN have similar market capitalizations ($1.61B and $1.60B).
Which one does Intratio's AI model rank higher, GENB or PGEN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.